IL125776A - Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors - Google Patents

Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors

Info

Publication number
IL125776A
IL125776A IL12577697A IL12577697A IL125776A IL 125776 A IL125776 A IL 125776A IL 12577697 A IL12577697 A IL 12577697A IL 12577697 A IL12577697 A IL 12577697A IL 125776 A IL125776 A IL 125776A
Authority
IL
Israel
Prior art keywords
drug
manufacture
dependent tumors
cimicifuga racemosa
treating estrogen
Prior art date
Application number
IL12577697A
Other languages
English (en)
Other versions
IL125776A0 (en
Original Assignee
Schaper & Brummer Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schaper & Brummer Gmbh & Co Kg filed Critical Schaper & Brummer Gmbh & Co Kg
Publication of IL125776A0 publication Critical patent/IL125776A0/xx
Publication of IL125776A publication Critical patent/IL125776A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12577697A 1996-12-14 1997-12-12 Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors IL125776A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652183A DE19652183C1 (de) 1996-12-14 1996-12-14 Verwendung eines Extraktes aus Cimicifuga racemosa
PCT/DE1997/002898 WO1998026791A1 (de) 1996-12-14 1997-12-12 Verwendung eines extraktes aus cimicifuga racemosa

Publications (2)

Publication Number Publication Date
IL125776A0 IL125776A0 (en) 1999-04-11
IL125776A true IL125776A (en) 2003-12-10

Family

ID=7814802

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12577697A IL125776A (en) 1996-12-14 1997-12-12 Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors

Country Status (13)

Country Link
US (1) US6267994B1 (no)
EP (1) EP0847755B1 (no)
AT (1) ATE205721T1 (no)
AU (2) AU730372B2 (no)
CA (1) CA2245890C (no)
DE (2) DE19652183C1 (no)
DK (1) DK0847755T3 (no)
ES (1) ES2163085T3 (no)
HU (1) HU224316B1 (no)
IL (1) IL125776A (no)
NO (1) NO316106B1 (no)
PL (1) PL187264B1 (no)
WO (1) WO1998026791A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
DE60022517T2 (de) * 1999-07-15 2006-08-03 Kobenhavns Universitet Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
DE10146159A1 (de) 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
US20030224069A1 (en) * 2002-06-03 2003-12-04 Ven Subbiah Triterpene glycosides for hormonal therapy
US20030224068A1 (en) * 2002-06-03 2003-12-04 Ven Subbiah Compounds for hormonal therapy
EP1519717B1 (en) * 2002-07-05 2010-09-29 Temrel Limited Controlled release composition
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20090186837A1 (en) 2002-12-27 2009-07-23 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20090264377A1 (en) * 2002-12-27 2009-10-22 Linda Saxe Einbond Anti-neoplastic compositions comprising extracts of black cohosh
JP2004307445A (ja) * 2003-04-02 2004-11-04 Pharmaton Sa Ｓｅｒｍの副作用を改善する方法
US20040228931A1 (en) * 2003-05-12 2004-11-18 Pharmachem Laboratories, Inc. Novel composition for hormonal balance and uses thereof
MXPA05013705A (es) * 2003-07-01 2006-03-08 Zeller Max Soehne Ag Metodo de extraccion de plantas y extracto.
DE102005005276A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Chemoprävention der Tumorgenese und/oder zur Inhibition der Tumorprogression bei endokrin-abhängigen und endokrin-unabhängigen Tumoren
EP2874637B1 (en) 2012-07-03 2019-08-14 Max Zeller Söhne AG Novel pharmacological use of cimicifuga extract
EP3906040A1 (en) * 2018-12-31 2021-11-10 Max Zeller Söhne AG Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis
IT201900000343A1 (it) 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02255622A (ja) * 1989-03-28 1990-10-16 Tsumura & Co 制癌補助剤
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders

Also Published As

Publication number Publication date
HU224316B1 (hu) 2005-07-28
EP0847755A1 (de) 1998-06-17
CA2245890A1 (en) 1998-06-25
AU4830097A (en) 1998-06-18
NO975858D0 (no) 1997-12-12
IL125776A0 (en) 1999-04-11
CA2245890C (en) 2010-05-25
DK0847755T3 (da) 2001-11-12
PL323617A1 (en) 1998-06-22
US6267994B1 (en) 2001-07-31
DE59704654D1 (de) 2001-10-25
ATE205721T1 (de) 2001-10-15
NO316106B1 (no) 2003-12-15
AU5549098A (en) 1998-07-15
HUP9901360A2 (hu) 1999-08-30
AU730372B2 (en) 2001-03-08
ES2163085T3 (es) 2002-01-16
NO975858L (no) 1998-06-15
PL187264B1 (pl) 2004-06-30
HUP9901360A3 (en) 2000-02-28
DE19652183C1 (de) 1998-02-12
WO1998026791A1 (de) 1998-06-25
EP0847755B1 (de) 2001-09-19

Similar Documents

Publication Publication Date Title
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
GR3034535T3 (en) Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer
GEP20002013B (en) Therapeutical Means
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
WO2001082961A3 (en) Methods for treating bone tumors
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
MY121548A (en) Compounds and methods for the treatment of cancer
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
EP0281070A3 (en) Pharmaceutical composition for the treatment of cancer
DK1124566T3 (da) Ikke-fermenteret osmotisk laxativ til behandling og forebyggelse af colorectale cancere
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
EP0835662A3 (en) A drug for the treatment of cancer
WO2002024148A3 (en) Method or treatment of tumors using transforming growth factor-alpha
MD798G2 (ro) Metoda de tratament a cancerului mamar
WO1999056697A3 (en) Pharmaceutical composition
JO2199B1 (en) Replaced pyrrols
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
EP0870510A3 (en) Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents
CA2197139A1 (en) A drug for the treatment of cancer
HK1058305A1 (en) Combinations of dalfopristine/quinupristine with cefpirome
MX9606137A (es) Composiciones y metodos para el tratamiento de tumores.
AU1018400A (en) Composition made of plant extracts, especially for use in cancer treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees